[Specific drug treatments for endometriosis]
This article reviews specific drug treatments for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
The provided text is a metadata record for an article titled "Specific drug treatments for endometriosis" published in La Revue de l'Infirmière. It does not contain the full scientific content, abstract, or data necessary to summarize specific study findings, methodologies, or results. The entry primarily serves as a gateway indicating access requirements for subscribers, healthcare practitioners, or researchers. Relevance to endometriosis: listed as one indication for GnRH antagonists, though the paper's main focus is uterine fibroids.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
593 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
References (1)
- W123337857 via openalex
Source provenance
- europepmc
- last seen: 2026-09-26T06:15:21.694264+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-09-26T06:13:31.997584+00:00